Finanzwire Finanzwire
Basculer en Français
10058 Companies
205602 Keywords
135838 Articles
109006 Press releases
Headlines Articles Press releases Morphogenesis Inc. Remove
  1. Home
  2. Companies
  3. Morphogenesis Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/25/2024 at 15:05, 1 year 10 months ago

    TuHURA Biosciences to Showcase Clinical Trial Results at ASCO 2024

    Clinical Trials Mergers And Acquisitions TuHURA Biosciences Cancer Immunotherapy ASCO 2024
  • PRESS RELEASE

    published on 04/25/2024 at 15:00, 1 year 10 months ago

    TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

    TuHURA Biosciences, Inc. announces IFx-2.0 Phase 1b trial results accepted for poster presentation at 2024 ASCO Annual Meeting. Company to form new entity with Kintara Therapeutics, Inc. and focus on cancer vaccines and bi-functional ADCs
    Phase 1b Trial TuHURA Biosciences Inc. IFx-2.0 Poster Presentation Kintara Therapeutics Inc.
    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 12/14/2023 at 16:00, 2 years 3 months ago

    Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview

    Logo of Morphogenesis Inc.
  • PRESS RELEASE

    published on 11/08/2023 at 15:00, 2 years 4 months ago

    Morphogenesis, Inc. Biomarker Analysis Data from IFx-Hu2.0 in Melanoma Refractory to Anti-PD1-Based Therapies Demonstrates Ability to Overcome Primary Resistance to Checkpoint Inhibitors and Trigger an Innate Immune Response

    Logo of Morphogenesis Inc.
Accesswire
  • Published on 03/20/2026 at 23:00, 1 day 2 hours ago

    Cypher Announces Private Placement

  • Published on 03/20/2026 at 21:30, 1 day 3 hours ago

    Sky Gold Sets Options

  • Published on 03/20/2026 at 21:15, 1 day 3 hours ago

    Earthwise Minerals Announces Private Placement

  • Published on 03/20/2026 at 13:30, 1 day 11 hours ago

    Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock

  • Published on 03/20/2026 at 12:30, 1 day 12 hours ago

    CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE
EQS Group
  • Published on 03/20/2026 at 22:45, 1 day 2 hours ago

    Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere

  • Published on 03/20/2026 at 21:05, 1 day 3 hours ago

    Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications

  • Published on 03/20/2026 at 21:05, 1 day 3 hours ago

    Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion

  • Published on 03/20/2026 at 21:00, 1 day 4 hours ago

    BRP Unveils the Winners of its 6th International Design Challenge

  • Published on 03/20/2026 at 20:05, 1 day 4 hours ago

    INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action

View all EQS
Les Echos
  • Published on 03/20/2026 at 19:00, 1 day 6 hours ago

    AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026

  • Published on 03/20/2026 at 18:15, 1 day 6 hours ago

    Publication of AXA’s 2025 Universal Registration Document

  • Published on 03/20/2026 at 17:45, 1 day 7 hours ago

    Cie du Bois Sauvage : Annual report 2025

  • Published on 03/20/2026 at 16:57, 1 day 8 hours ago

    Number of shares and voting rights - February 2026 (In French only)

  • Published on 03/19/2026 at 18:00, 2 days 7 hours ago

    Filing of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy